Printed From:

SKIP
SWIPE TO EXPLORE

Different Manifestations Across Patients
Type 2 Inflammation May Be A Clear Connection

Type 2 inflammation is characterized by immune dysregulation and epithelial barrier dysfunction—both provide evidence of Type 2 pathway activation in disease1-3

CRS, chronic rhinosinusitis.

  1. Gandhi NA, Bennett BL, Graham NMH, Pirozzi G, Stahl N, Yancopoulos GD. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016;15(1):35-50.
  2. Robinson D, Humbert M, Buhl R, et al. Revisiting type 2-high and type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy. 2017;47(2):161-175.
  3. Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol. 2008;8(3):193-204.

Watch how Type 2 inflammation can affect
a range of patients1

Watch how Type 2 Inflammation can affect
a range of patients1

Watch how Type 2 Inflammation can affect
a range of patients1

Watch how Type 2 Inflammation can affect
a range of patients1

APPROVED FOR 3 INDICATIONS


EXPLORE ADDITIONAL
INDICATIONS

CRS, chronic rhinosinusitis.

  1. Gandhi NA, Bennett BL, Graham NMH, Pirozzi G, Stahl N, Yancopoulos GD. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016;15(1):35-50.
  2. Robinson D, Humbert M, Buhl R, et al. Revisiting type 2-high and type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy. 2017;47(2):161-175.
  3. Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol. 2008;8(3):193-204.